These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9412668)

  • 1. Dose-volume histograms can be interpreted in different ways.
    Jayaraman S; Asbell SO
    Cancer Invest; 1997; 15(6):611-3. PubMed ID: 9412668
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of treatment techniques for conformal radiotherapy of the prostate using dose-volume histograms and normal tissue complication probabilities.
    Roach M
    Radiother Oncol; 1996 Jul; 40(1):85-7. PubMed ID: 8844893
    [No Abstract]   [Full Text] [Related]  

  • 3. Correlation between surrogates of bladder dosimetry and dose-volume histograms of the bladder wall defined on MRI in prostate cancer radiotherapy.
    Carillo V; Cozzarini C; Chietera A; Perna L; Gianolini S; Maggio A; Botti A; Rancati T; Valdagni R; Fiorino C
    Radiother Oncol; 2012 Nov; 105(2):180-3. PubMed ID: 23182056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-surface histograms as treatment planning tool for prostate conformal therapy.
    Lu Y; Li S; Spelbring D; Song P; Vijayakumar S; Pelizzari C; Chen GT
    Med Phys; 1995 Mar; 22(3):279-84. PubMed ID: 7596316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of treatment techniques for conformal radiotherapy of the prostate using dose-volume histograms and normal tissue complication probabilities.
    Neal AJ; Oldham M; Dearnaley DP
    Radiother Oncol; 1995 Oct; 37(1):29-34. PubMed ID: 8539454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of organ at risk definition on rectal dose-volume histograms in patients with prostate cancer undergoing external-beam radiotherapy.
    Boehmer D; Kuczer D; Badakhshi H; Stiefel S; Kuschke W; Wernecke KD; Budach V
    Strahlenther Onkol; 2006 May; 182(5):277-82. PubMed ID: 16673061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological dose volume histograms during conformal hypofractionated accelerated radiotherapy for prostate cancer.
    Koukourakis MI; Abatzoglou I; Touloupidis S; Manavis I
    Med Phys; 2007 Jan; 34(1):76-80. PubMed ID: 17278492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absolute and relative dose-surface and dose-volume histograms of the bladder: which one is the most representative for the actual treatment?
    Hoogeman MS; Peeters ST; de Bois J; Lebesque JV
    Phys Med Biol; 2005 Aug; 50(15):3589-97. PubMed ID: 16030384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. External beam radiotherapy of localized prostatic adenocarcinoma. Evaluation of conformal therapy, field number and target margins.
    Lennernäs B; Rikner G; Letocha H; Nilsson S
    Acta Oncol; 1995; 34(7):953-8. PubMed ID: 7492387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Monte Carlo study of the impact of the choice of rectum volume definition on estimates of equivalent uniform doses and the volume parameter.
    Kvinnsland Y; Muren LP; Dahl O
    Phys Med Biol; 2004 Aug; 49(15):3341-52. PubMed ID: 15379017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New wine in an old bottle? Dose escalation under dose-volume constraints: a model of conformal therapy of the prostate.
    Kutcher GJ; Leibel SA; Ling CC; Zelefsky M; Fuks Z
    Int J Radiat Oncol Biol Phys; 1996 May; 35(2):415-6. PubMed ID: 8635953
    [No Abstract]   [Full Text] [Related]  

  • 12. [The procedure of intensity-modulated radiotherapy (IMRT) treatment planning for prostate cancer].
    Hanyu Y
    Nihon Hoshasen Gijutsu Gakkai Zasshi; 2007 Nov; 63(11):1303-9. PubMed ID: 18187915
    [No Abstract]   [Full Text] [Related]  

  • 13. The use of a multi-leaf collimator for conformal radiotherapy of carcinomas of the prostate and nasopharynx.
    LoSasso T; Chui CS; Kutcher GJ; Leibel SA; Fuks Z; Ling CC
    Int J Radiat Oncol Biol Phys; 1993 Jan; 25(2):161-70. PubMed ID: 8420865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New 125I dosimetry in prostatic brachytherapy planning.
    Piermattei A
    Rays; 1993; 18(1):58-62. PubMed ID: 8356241
    [No Abstract]   [Full Text] [Related]  

  • 15. [Conformal radiotherapy: arguments against].
    Eschwège F
    Cancer Radiother; 1998; 2(1):81. PubMed ID: 9749103
    [No Abstract]   [Full Text] [Related]  

  • 16. Dose rate in external beam radiotherapy for prostate cancer: an overlooked confounding variable?
    Welsh JS; Howard SP; Fowler JF
    Urology; 2003 Aug; 62(2):204-6. PubMed ID: 12893319
    [No Abstract]   [Full Text] [Related]  

  • 17. External beam radiotherapy in the treatment of prostatic carcinoma: technical procedures.
    Chiavacci A; Cappellini M
    Rays; 1993; 18(1):33-44. PubMed ID: 8356239
    [No Abstract]   [Full Text] [Related]  

  • 18. Three-dimensional conformal therapy (3D-CRT) for prostate cancer.
    Chuba PJ; Porter AT; Forman JD
    Cancer Treat Res; 1996; 88():147-65. PubMed ID: 9239478
    [No Abstract]   [Full Text] [Related]  

  • 19. Three-dimensional conformal radiation therapy in locally advanced carcinoma of the prostate: preliminary results of a phase I dose escalation study.
    Phillips TL
    Int J Radiat Oncol Biol Phys; 1994 Jan; 28(1):325-6; discussion 327-8. PubMed ID: 8270457
    [No Abstract]   [Full Text] [Related]  

  • 20. Comment on Moerland et al. study of decline of dose coverage between different implant techniques for I125 prostate brachytherapy.
    Al-Qaisieh B
    Radiother Oncol; 2010 Mar; 94(3):386-7; author reply 386. PubMed ID: 20207039
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.